James H Cavanaugh's Net Worth
Estimate Recalculated Nov 1, 2024 02:24PM EST
Who is James H Cavanaugh
James H Cavanaugh has an estimated net worth of $6.45 Million. This is based on reported shares across multiple companies, which include DIACRIN INC /DE/, TETRALOGIC PHARMACEUTICALS Corp, Radius Health, Inc., HEALTHCARE ACQUISITION CORP, REPLIDYNE INC, TREVENA INC, PROTEOSTASIS THERAPEUTICS, INC., THRESHOLD PHARMACEUTICALS INC, GLOBEIMMUNE INC, CRITICAL THERAPEUTICS INC, MEMORY PHARMACEUTICALS CORP, ADVANCIS PHARMACEUTICAL CORP, ACTIVBIOTICS INC, LEAP THERAPEUTICS, INC., VERENIUM CORP, SHIRE PHARMACEUTICALS GROUP PLC, MEDIMMUNE INC /DE, and VICURON PHARMACEUTICALS INC.
SEC CIK
James H Cavanaugh's CIK is 0001013473
Past Insider Trading and Trends
2009 was James H Cavanaugh's most active year for acquiring shares with 24 total transactions. James H Cavanaugh's most active month to acquire stocks was the month of October. 2009 was James H Cavanaugh's most active year for disposing of shares, totalling 10 transactions. James H Cavanaugh's most active month to dispose stocks was the month of September. 2011 saw James H Cavanaugh paying a total of $491,032.84 for 193,305 shares, this is the most they've acquired in one year. In 2007 James H Cavanaugh cashed out on 276,590 shares for a total of $5,892,220.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
